CTS Corp

CTS Corp

IndustrialsElectronic & Electrical Equipment
  • Price (USD)34.25
  • Today's Change2.53 / 7.98%
  • Shares traded236.37k
  • 1 Year change+29.00%
  • Beta0.7600
Data delayed at least 15 minutes, as of Oct 27 2021 21:10 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

CTS Corporation is a manufacturer of sensors, connectivity components, and actuators. The Company designs, manufactures, and sells a line of sensors, connectivity components, and actuators primarily to original equipment manufacturers (OEMs) and supplies for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Its products perform specific electronic functions for a given product family and are intended for use in customer assemblies. The Company’s products consist principally of sensors and actuators used in passenger or commercial vehicles, connectivity components used in telecommunications infrastructure, information technology and other high-speed applications, switches, temperature sensors, and potentiometers supplied to multiple markets, and fabricated piezoelectric materials and substrates used primarily in medical, industrial, aerospace and defense, and information technology markets.

  • Revenue in USD (TTM)503.41m
  • Net income in USD-36.08m
  • Incorporated1929
  • Employees3.79k
  • Location
    CTS Corp4925 Indiana AveLISLE 60532-1611United StatesUSA
  • Phone+1 (630) 577-8800
  • Fax+1 (574) 294-5178
  • Websitehttps://www.ctscorp.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
CTS:NYQ since
Sensor Scientific IncDeal completed30 Dec 202030 Dec 2020Deal completed1.90%--
Data delayed at least 15 minutes, as of Oct 27 2021 21:10 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Diebold Nixdorf Inc3.99bn-191.00m791.37m22.00k------0.1984-2.45-2.4551.15-10.871.105.226.50181,295.50-5.20-6.65-9.18-11.7428.0123.25-4.73-6.880.77220.55631.56---11.4910.0321.15---12.06--
908 Devices Inc.25.59m-25.50m884.77m101.00--6.96--34.58-1.34-1.341.034.600.24791.922.45253,316.80-24.68---27.28--53.55---99.54--13.35-20.400.1059--49.64--4.25------
CTS Corporation503.41m-36.08m1.11bn3.79k--2.43--2.21-1.12-1.1215.4714.100.76987.036.51132,966.50-5.526.56-6.527.9835.4934.01-7.178.422.1656.490.098614.24-9.582.09-4.0437.918.850.00
FARO Technologies, Inc.322.13m19.99m1.27bn1.36k65.093.5638.153.941.071.0717.7819.660.67332.855.96236,165.704.18-10.305.24-12.6353.69--6.20-17.062.36--0.0008---20.43-0.8834101.01-45.27-17.93--
Cue Health Inc219.92m4.77m1.29bn1.25k269.98--87.535.850.03320.03321.530.7999------175,370.80--------54.47--2.17--2.081.680.696--246.41---129.80------
IMPINJ Inc174.16m-46.96m1.36bn310.00------7.80-1.98-1.987.31--0.84863.087.78561,796.80-22.88-15.94-33.11-18.4650.0649.36-26.97-19.811.35-14.380.4852---9.1012.10-125.88---16.23--
BioNano Genomics Inc13.21m-51.26m1.41bn147.00--4.07--106.71-0.2609-0.26090.06341.240.06882.154.3489,863.81-26.69---28.98--33.28---388.00--31.41-24.420.00---16.06---37.87------
Berkeley Lights Inc77.83m-54.46m1.55bn230.00--6.69--19.94-0.8322-0.83221.193.460.3752.054.35338,408.70-26.17---29.76--67.83---69.79--8.84-45.550.0782--13.42---101.48------
Mesa Laboratories, Inc.138.92m4.05m1.59bn506.00445.303.9870.9711.430.68540.685425.9776.750.23364.007.22274,537.600.68151.580.71381.7363.9858.892.923.739.061.750.297264.5813.819.61142.70-21.76-23.750.00
Data as of Oct 27 2021. Currency figures normalised to CTS Corp's reporting currency: US Dollar USD

Institutional shareholders

58.09%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Jun 20214.78m14.75%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Jun 20213.52m10.85%
The Vanguard Group, Inc.as of 30 Jun 20212.06m6.34%
Wellington Management Co. LLPas of 30 Jun 20211.76m5.44%
Dimensional Fund Advisors LPas of 30 Jun 20211.54m4.76%
GAMCO Asset Management, Inc.as of 30 Jun 20211.52m4.68%
Goldman Sachs Asset Management LPas of 30 Jun 20211.11m3.42%
SSgA Funds Management, Inc.as of 30 Jun 20211.05m3.25%
Northern Trust Investments, Inc.(Investment Management)as of 30 Jun 2021765.32k2.36%
Brown Advisory LLCas of 30 Jun 2021730.50k2.25%
More ▼
Data from 30 Jun 2021 - 30 Jun 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.